Literature DB >> 28663356

Appendiceal Mucinous Neoplasms: Diagnosis and Management.

Walid L Shaib1,2, Rita Assi3, Ali Shamseddine3, Olatunji B Alese4,2, Charles Staley5, Bahar Memis6, Volkan Adsay6, Tanios Bekaii-Saab7, Bassel F El-Rayes4,2.   

Abstract

OBJECTIVE: Appendiceal mucinous neoplasms (AMNs) are a rare and heterogeneous disease for which clinical management is challenging. We aim to review the literature regarding modalities of treatment to guide the management of AMNs. METHODS AND REVIEW CRITERIA: We conducted a PubMed search in February 2016 for English-language publications, using the terms "appendiceal," "appendix," "carcinoma," "cancer," "mucinous," "treatment," "genes," "target," "genomic," and terms listed in the articles' subheadings. Published reports and abstracts from the American Society of Clinical Oncology meetings were also searched.
RESULTS: In this review, we summarize current data and controversies in AMN classification, clinical presentation, molecular alterations, treatment outcomes with regard to cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and the role of systemic chemotherapy.
CONCLUSION: Appendiceal mucinous neoplasms are a heterogeneous group of tumors with a rising incidence. Treatment is based on stage and histology. Low-grade tumors are treated surgically with resection of the primary site in early stage disease, or peritoneal debulking and HIPEC in patients with advanced stage disease. Treatment of high-grade tumors requires further prospective trials, and options include debulking surgery and HIPEC with or without preoperative chemotherapy. Trials evaluating novel therapies based on the molecular profiling of AMN tumors are needed to evaluate therapeutic options in patients who are not surgical candidates. IMPLICATIONS FOR PRACTICE: This review provides a reference to guide gastroenterologists, pathologists, surgeons, and oncologists in the management of appendiceal mucinous neoplasms (AMNs), a rare and heterogeneous disease with no consensus on histologic classification or guidelines for treatment algorithms. This review summarizes all AMN classifications and proposes a treatment algorithm based on stage and histology of disease. © AlphaMed Press 2017.

Entities:  

Keywords:  Abdominal surgery; Appendix carcinoma; Review

Mesh:

Year:  2017        PMID: 28663356      PMCID: PMC5599200          DOI: 10.1634/theoncologist.2017-0081

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  68 in total

Review 1.  The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

Authors:  D C Chung
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

2.  Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998.

Authors:  Margaret E McCusker; Timothy R Coté; Limin X Clegg; Leslie H Sobin
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

3.  Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.

Authors:  P H Sugarbaker; D Chang
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

Review 4.  Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms.

Authors:  Robert H Young
Journal:  Semin Diagn Pathol       Date:  2004-05       Impact factor: 3.464

5.  Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.

Authors:  Joseph Misdraji; Rhonda K Yantiss; Fiona M Graeme-Cook; Ulysses J Balis; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

6.  Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  P H Sugarbaker; K A Jablonski
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

7.  Clinicopathological analysis of primary epithelial appendiceal neoplasms.

Authors:  Sachin Gupta; Venkata Parsa; Volkan Adsay; Lance K Heilbrun; Daryn Smith; Anthony F Shields; Donald Weaver; Philip A Philip; Bassel F El-Rayes
Journal:  Med Oncol       Date:  2009-10-23       Impact factor: 3.064

8.  Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding.

Authors:  S González-Moreno; P H Sugarbaker
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

9.  Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases.

Authors:  Michelle D Reid; Olca Basturk; Walid L Shaib; Yue Xue; Serdar Balci; Hye-Jeong Choi; Gizem Akkas; Bahar Memis; Brian S Robinson; Bassel F El-Rayes; Charles A Staley; Christopher A Staley; Joshua H Winer; Maria C Russell; Jessica H Knight; Michael Goodman; Alyssa M Krasinskas; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-06-24       Impact factor: 7.842

10.  Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival.

Authors:  Lana Bijelic; Anjali S Kumar; O Anthony Stuart; Paul H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-26       Impact factor: 2.260

View more
  29 in total

1.  Feasibility, acceptance, safety, and effectiveness of antibiotic therapy as alternative treatment approach to appendectomy in uncomplicated acute appendicitis.

Authors:  Daniela Prechal; Stefan Post; Ioanna Pechlivanidou; Ulrich Ronellenfitsch
Journal:  Int J Colorectal Dis       Date:  2019-09-12       Impact factor: 2.571

2.  Genomic Landscape of Appendiceal Neoplasms.

Authors:  Celina S-P Ang; John Paul Shen; Camille J Hardy-Abeloos; Justin K Huang; Jeffrey S Ross; Vincent A Miller; Miriam T Jacobs; Ingrid L Chen; David Xu; Siraj M Ali; Joel Baumgartner; Andrew Lowy; Paul Fanta; Trey Ideker; Sherri Z Millis; Olivier Harismendy
Journal:  JCO Precis Oncol       Date:  2018-08-08

3.  Delivery of an Incidental Appendiceal Mucinous Neoplasm.

Authors:  Madison Bowles; Jessica Y Ng; Hajir Nabi
Journal:  Cureus       Date:  2022-06-22

Review 4.  Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Authors:  Beate Rau; Linda Feldbrügge; Felix Gronau; Miguel Enrique Alberto Vilchez; Peter Thuss-Patience; Pierre Emmanuel Bonnot; Olivier Glehen
Journal:  Visc Med       Date:  2022-02-23

5.  Organoids From Mucinous Appendiceal Adenocarcinomas as High-Fidelity Models for Individual Therapy.

Authors:  Guangyao Liu; Xing Xiao; Yujian Xia; Weibing Huang; Wei Chen; Jiannan Xu; Songyao Chen; Huijin Wang; Jitao Wei; Huan Li; Man Shu; Xiaofang Lu; Changhua Zhang; Yulong He
Journal:  Front Med (Lausanne)       Date:  2022-06-02

6.  Nomenclature of appendiceal mucinous lesions according to the 2019 WHO Classification of Tumors of the Digestive System.

Authors:  Cemalettin Koç; Sami Akbulut; Ayşe Nur Akatlı; Emine Türkmen Şamdancı; Adem Tuncer; Sezai Yılmaz
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

7.  Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.

Authors:  Walid L Shaib; Katerina Zakka; Charles Staley; Ali Roberts; Mehmet Akce; Christina Wu; Olatunji B Alese; Bassel F El-Rayes
Journal:  Oncologist       Date:  2019-11-29

8.  Grincamycins P-T: Rearranged Angucyclines from the Marine Sediment-Derived Streptomyces sp. CNZ-748 Inhibit Cell Lines of the Rare Cancer Pseudomyxoma Peritonei.

Authors:  Zhuo Shang; Zachary E Ferris; Douglas Sweeney; Alexander B Chase; Chunhua Yuan; Yvonne Hui; Lukuan Hou; Ethan A Older; Dan Xue; Xiaoyu Tang; Weipeng Zhang; Prakash Nagarkatti; Mitzi Nagarkatti; Traci L Testerman; Paul R Jensen; Jie Li
Journal:  J Nat Prod       Date:  2021-04-26       Impact factor: 4.050

9.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience.

Authors:  Giulia Montori; Federico Coccolini; Paola Fugazzola; Marco Ceresoli; Matteo Tomasoni; Carolina Rubicondo; Stefano Raimondo; Domenico Pinelli; Michele Colledan; Luigi Frigerio; Luca Ansaloni
Journal:  J Gastrointest Oncol       Date:  2018-04

Review 10.  What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.

Authors:  Naziheh Assarzadegan; Elizabeth Montgomery
Journal:  Arch Pathol Lab Med       Date:  2021-06-01       Impact factor: 5.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.